Showing results (911-920 of 944) with videos related to

Sort By:
Pageof 95
Neurology and Therapy|October 25, 2024
Effects of Manual Acupuncture Versus Sham Acupuncture in patients with Post-Stroke Depression: A Randomized Clinical TrialConghui Wei, Jinling Chen, Qu Yang, et al.
Neurology and Therapy|May 29, 2026
Cenobamate: An Appraisal Five Years OnEugen Trinka, John Paul Leach, Josemir W Sander
Neurology and Therapy|May 30, 2026
Early Versus Delayed Treatment with Ocrelizumab: A Multicenter, Real-World Observational Study in People with Multiple SclerosisEnrique Alvarez, Robert T Naismith, Le H Hua, et al.
Neurology and Therapy|March 13, 2026
Impact of Anti-CD20 Therapies on Cytokine, Chemokine and Adhesion Molecule Dynamics in Multiple Sclerosis: A Narrative ReviewMarc Messner, Josef-Martin Mitterwallner, Michael Unterhofer, et al.
Neurology and Therapy|April 11, 2026
Practical Recommendations for Cardiology Follow-Up in Patients Treated with Fenfluramine Based on Expert Opinion and Clinical ExperienceAntonio Gil-Nagel, Leopoldo Pérez de la Isla, Elena Sanz Pascual, et al.
Neurology and Therapy|June 7, 2026
Differential Effects of High and Low Frequency Subthalamic Nucleus Deep Brain Stimulation on Force Steadiness in Patients with Parkinson's Disease: An Exploratory StudyAmin Olamazadeh, Steffen Brenner, Daniela Souza de Oliveira, et al.
Neurology and Therapy|July 25, 2023
Blood-Brain Barrier Breakdown is a Sensitive Biomarker of Cognitive and Language Impairment in Patients with White Matter HyperintensitiesXing Wang, Yulu Shi, Yiyi Chen, et al.
Neurology and Therapy|July 17, 2023
Real-World Clinical and Economic Outcomes Among Persons With Multiple Sclerosis Initiating First- Versus Second- or Later-Line Treatment With OcrelizumabCaroline K Geiger, Danny Sheinson, Tu My To, et al.
Neurology and Therapy|June 22, 2023
Effects of the COVID-19 Pandemic on SMA Screening and Care: Physician and Community InsightsMary Curry, Ilse Peterson, Lisa Belter, et al.
Neurology and Therapy|June 13, 2023
Dietary Patterns and Their Associations with Symptom Levels Among People with Multiple Sclerosis: A Real-World Digital StudyLasse Skovgaard, Philipp Trénel, Katrine Westergaard, et al.
Pageof 95